Skip to content
Evigrade
CriticalErgot alkaloid, 5-HT1B/1D and alpha-adrenoceptor agonist×Imidazole antifungal

Updated · Methodology

Mechanism

The liver metabolises ergotamine mainly through the enzyme CYP3A4 (ergotamine/caffeine summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS), and the miconazole oral gel SmPC calls miconazole a clinically potent inhibitor of this enzyme (miconazole oral gel SmPC, AEMPS). According to the gel SmPC, oral miconazole must not be combined with ergot alkaloids, including ergotamine, because their higher blood levels can cause ergotism, that is, ergot alkaloid poisoning (AEMPS). The Spanish ergotamine/caffeine SmPC states that CYP3A inhibitors, including azole antifungals, can increase ergotamine exposure and toxicity, with possible vasospasm and ischaemia of the limbs or coronary arteries and stroke (AEMPS). According to the US ergotamine label, acute ergotism with vasospasm and limb ischaemia has been reported when ergotamine was combined with potent CYP3A4 inhibitors, and some cases led to amputation (ergotamine label, US Food and Drug Administration, FDA). Patients hold the gel in the mouth and then swallow it. A 60 mg dose of the gel gives peak plasma miconazole levels of 31–49 ng/mL (miconazole oral gel SmPC, AEMPS). Less than 1% of a cream dose is absorbed (miconazole cream SmPC, AEMPS). Each Spanish vaginal ovule contains 100 mg of miconazole with 300 mg of metronidazole. Their SmPC gives data for 1200 mg miconazole ovules: levels more than 100 times lower than after oral or intravenous use (vaginal ovule SmPC, AEMPS).

Symptoms

Early signs of ergotamine-induced vasospasm are numbness and tingling in the fingers and toes, headache and chest pain (ergotamine/caffeine summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). In ergotism the arteries narrow intensely: the limbs become numb, painful and bluish, the pulses disappear, gangrene can develop without treatment, and vasospasm can also affect the kidneys or the brain (AEMPS). Ergotamine can cause myocardial ischaemia and, rarely, myocardial infarction, even in people with no known coronary heart disease (AEMPS). Overdose causes nausea, vomiting, drowsiness, confusion, fast heart rate, dizziness, respiratory depression, low blood pressure, seizures, shock and coma (AEMPS).

Management

The combination is contraindicated for oral miconazole. The miconazole oral gel summary of product characteristics (SmPC) names ergotamine among the ergot alkaloids that must not be used with oral miconazole (miconazole oral gel SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The Spanish ergotamine/caffeine SmPC contraindicates azole antifungals and does not separate them by dosage form (ergotamine/caffeine SmPC, AEMPS). The US ergotamine label contraindicates potent CYP3A4 inhibitors (ergotamine label, US Food and Drug Administration, FDA). Miconazole is not among its examples, but the gel SmPC itself calls miconazole a clinically potent CYP3A4 inhibitor (miconazole oral gel SmPC, AEMPS). Patients hold the gel in the mouth and then swallow it, so the contraindication also applies when it is used for oral or oesophageal candidiasis (miconazole oral gel SmPC, AEMPS). The miconazole cream and vaginal ovule SmPCs do not mention ergot alkaloids. According to them, little miconazole reaches the blood and clinically relevant interactions are rare (miconazole cream and vaginal ovule SmPCs, AEMPS). The ovules also contain metronidazole, and 20–25% of it is absorbed from the ovule (vaginal ovule SmPC, AEMPS). The US ergotamine label lists metronidazole among less potent CYP3A4 inhibitors: serious reactions have not been reported with them, but there is a potential risk of serious toxicity, including vasospasm (ergotamine FDA label). The US label of miconazole buccal tablets, which are not available in Spain, states that absorption is minimal but that an interaction with ergot alkaloids cannot be ruled out (miconazole FDA label). If numbness or tingling in the fingers, chest pain or other signs of vasospasm appear, stop ergotamine at once and start a peripheral vasodilator. In severe vasospasm, give an intravenous vasodilator such as sodium nitroprusside, phentolamine or dihydralazine. For coronary vasospasm, start treatment, for example with nitroglycerin (ergotamine/caffeine SmPC, AEMPS).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Ergotamine

Other interactions with Miconazole